lobbying_filings_raw: 21117108-91c7-4cdc-9dc9-5cf7d887abc4
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21117108-91c7-4cdc-9dc9-5cf7d887abc4 | 4T | 401103474 | AVANIR PHARMACEUTICALS | 198934 | AVANIR PHARMACEUTICALS | 2022 | fourth_quarter | 2022-11-22T09:03:47-05:00 | 0 | 0 | 1 | {"url": "https://lda.senate.gov/api/v1/filings/21117108-91c7-4cdc-9dc9-5cf7d887abc4/", "filing_uuid": "21117108-91c7-4cdc-9dc9-5cf7d887abc4", "filing_type": "4T", "filing_type_display": "4th Quarter - Termination", "filing_year": 2022, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/21117108-91c7-4cdc-9dc9-5cf7d887abc4/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "40000.00", "expenses_method": "A", "expenses_method_display": "A", "posted_by_name": "Krista Clark", "dt_posted": "2022-11-22T09:03:47-05:00", "termination_date": "2022-11-15", "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "30 Enterprise", "registrant_address_2": "Suite 400", "registrant_different_address": false, "registrant_city": "Aliso Viejo", "registrant_state": "CA", "registrant_zip": "92656", "registrant": {"id": 401103474, "url": "https://lda.senate.gov/api/v1/registrants/401103474/", "house_registrant_id": null, "name": "AVANIR PHARMACEUTICALS", "description": "â\u20ac\u2039Central Nervous System Pharmaceutical Research and Development/Pharmaceutical Sales", "address_1": "30 Enterprise", "address_2": "Suite 400", "address_3": null, "address_4": null, "city": "Aliso Viejo", "state": "CA", "state_display": "California", "zip": "92656", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "KRISTA CLARK", "contact_telephone": "+1 949-389-6768", "dt_updated": "2023-06-06T16:25:15.024382-04:00"}, "client": {"id": 198934, "url": "https://lda.senate.gov/api/v1/clients/198934/", "client_id": 12, "name": "AVANIR PHARMACEUTICALS", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2021-08-18"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 19, S. 2164, Lower Costs, More Cures Act of 2021. H.R. 5376, Build Back Better Act, specifically issues dealing with Medicare.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 121752, "prefix": null, "prefix_display": null, "first_name": "CATHERINE", "nickname": null, "middle_name": "DRATZ", "last_name": "FERGUSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "H.R.7667 - Food and Drug Amendments of 2022, specifically provisions regarding the Prescription Drug User Fee Act (PDUFA). H.R.5376 - Inflation Reduction Act of 2022, specifically provisions relating to prescription drug pricing. Issues related to mental health.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 121752, "prefix": null, "prefix_display": null, "first_name": "CATHERINE", "nickname": null, "middle_name": "DRATZ", "last_name": "FERGUSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | CA | US | CA | CA | US | US | 0 | 0 | 40000.0 |